Sinusitus in the person with HIV infection. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Sinusitus in the person with HIV infection.

Annu Conf Australas Soc HIV Med. 1993 Oct 28-30;5:34 (abstract no. FC5). Unique Identifier : AIDSLINE ASHM5/94348961
van der Horst C; University of North Carolina.


Abstract: Although sinusitus is not a fatal complication of HIV infection it is nonetheless a vexing problem for my patients. The incidence and severity worsens as CD4 count declines and is often associated with intranasal drug use. Higher IgE levels are associated with worse sinusitis and atopy. Treatment must include intranasal steroids and perhaps decongestants. In the patient with elevated CD4 counts who presents with first an initial episode of sinusitis and is not on systemic antibiotics such as tmp/smx, rifabutin or clarithromycin empiric therapy with a cheap B-lactam is possible. Infections that do not respond or that occur in the face of systemic oral therapy warrant a radiologic examination, consideration of a sinus tap, and treatment with intravenous antibiotics. Chronic infection should suggest infection with fungi, anaerobes, staph aureus, and other resistant organisms.
Keywords: AIDS-Related Opportunistic Infections/DRUG THERAPY/*ETIOLOGY Chronic Disease Clarithromycin/THERAPEUTIC USE Diagnosis, Differential Human Rifabutin/THERAPEUTIC USE Sinusitis/DRUG THERAPY/*ETIOLOGY Trimethoprim-Sulfamethoxazole Combination/THERAPEUTIC USE ABSTRACTKWDaids-relatedopportunisticinfections/drugtherapy/KWDetiologychronicdiseaseclarithromycin/therapeuticusediagnosis,differentialhumanrifabutin/therapeuticusesinusitis/drugtherapy/KWDetiologytrimethoprim-sulfamethoxazolecombination/therapeuticuseabstract
941230
M94C4266

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .